Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

424 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A compilation answering 50 questions on monkeypox virus and the current monkeypox outbreak.
Cabanillas B, Murdaca G, Guemari A, Torres MJ, Azkur AK, Aksoy E, Vitte J, de Las Vecillas L, Giovannini M, Fernández-Santamaria R, Castagnoli R, Orsi A, Amato R, Giberti I, Català A, Ambrozej D, Schaub B, Tramper-Stranders GA, Novak N, Nadeau KC, Agache I, Akdis M, Akdis CA. Cabanillas B, et al. Among authors: orsi a. Allergy. 2023 Mar;78(3):639-662. doi: 10.1111/all.15633. Epub 2023 Jan 11. Allergy. 2023. PMID: 36587287 Review.
Long follow-up of BNT162b2 mRNA vaccine in healthcare workers (2020-2022): A retrospective longitudinal SARS-CoV-2 serological surveillance.
De Pace V, Bruzzone B, Ricucci V, Calcavecchia N, Guarona G, Giberti I, Costa E, Ogliastro M, Galano B, Nigro N, Murgia D, Nanni L, Orsi A. De Pace V, et al. Among authors: orsi a. Hum Vaccin Immunother. 2023 Aug;19(2):2258632. doi: 10.1080/21645515.2023.2258632. Epub 2023 Sep 19. Hum Vaccin Immunother. 2023. PMID: 37724517 Free PMC article.
Seroprotection against tetanus in the Italian general population.
Bagordo F, Grassi T, Rota MC, Castiglia P, Baldovin T, Della Polla G, Panico A, Ogliastro M, Marchi S, Vicentini C, Immordino P, Savio M, Gabutti G; Sero-epidemiological Study Group. Bagordo F, et al. Vaccine. 2024 May 17:S0264-410X(24)00561-9. doi: 10.1016/j.vaccine.2024.05.015. Online ahead of print. Vaccine. 2024. PMID: 38762356 Free article.
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19.
Baldi F, Dentone C, Mikulska M, Fenoglio D, Mirabella M, Magnè F, Portunato F, Altosole T, Sepulcri C, Giacobbe DR, Uras C, Scavone G, Taramasso L, Orsi A, Cittadini G, Filaci G, Bassetti M. Baldi F, et al. Among authors: orsi a. Front Med (Lausanne). 2023 Jan 9;9:1062450. doi: 10.3389/fmed.2022.1062450. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36698815 Free PMC article.
Brand-specific estimates of influenza vaccine effectiveness for the 2021-2022 season in Europe: results from the DRIVE multi-stakeholder study platform.
Stuurman AL, Carmona A, Biccler J, Descamps A, Levi M, Baum U, Mira-Iglesias A, Bellino S, Hoang U, de Lusignan S, Bonaiuti R, Lina B, Rizzo C, Nohynek H, Díez-Domingo J; DRIVE Study Contributors. Stuurman AL, et al. Front Public Health. 2023 Jul 20;11:1195409. doi: 10.3389/fpubh.2023.1195409. eCollection 2023. Front Public Health. 2023. PMID: 37546295 Free PMC article.
RSV Disease Burden in Primary Care in Italy: A Multi-Region Pediatric Study, Winter Season 2022-2023.
Scarpaci M, Bracaloni S, Esposito E, De Angelis L, Baglivo F, Casini B, Panatto D, Ogliastro M, Loconsole D, Chironna M, Pariani E, Pellegrinelli L, Pandolfi E, Croci I, Rizzo C; RSVComNet Italia. Scarpaci M, et al. Influenza Other Respir Viruses. 2024 Apr;18(4):e13282. doi: 10.1111/irv.13282. Influenza Other Respir Viruses. 2024. PMID: 38622776 Free PMC article.
424 results